Avivagen Inc. (VIVXF)
- Previous Close
0.0012 - Open
0.0064 - Bid --
- Ask --
- Day's Range
0.0012 - 0.0012 - 52 Week Range
0.0004 - 0.0149 - Volume
400 - Avg. Volume
719 - Market Cap (intraday)
284,510 - Beta (5Y Monthly) 1.06
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date May 16, 2024 - May 19, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.
www.avivagen.com--
Full Time Employees
October 31
Fiscal Year Ends
Sector
Recent News: VIVXF
Performance Overview: VIVXF
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VIVXF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VIVXF
Valuation Measures
Market Cap
284.24k
Enterprise Value
5.57M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.16
Price/Book (mrq)
--
Enterprise Value/Revenue
10.64
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-193.44%
Return on Equity (ttm)
--
Revenue (ttm)
715.22k
Net Income Avi to Common (ttm)
-4.64M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
17.18k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-851.4k
Research Analysis: VIVXF
Company Insights: VIVXF
VIVXF does not have Company Insights